These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19171036)

  • 1. Characterization of SV-40 Tag rats as a model to study prostate cancer.
    Harper CE; Patel BB; Cook LM; Wang J; Shirai T; Eltoum IA; Lamartiniere CA
    BMC Cancer; 2009 Jan; 9():30. PubMed ID: 19171036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.
    Harper CE; Cook LM; Patel BB; Wang J; Eltoum IA; Arabshahi A; Shirai T; Lamartiniere CA
    Prostate; 2009 Nov; 69(15):1668-82. PubMed ID: 19670229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat.
    Wang Z; Luque RM; Kineman RD; Ray VH; Christov KT; Lantvit DD; Shirai T; Hedayat S; Unterman TG; Bosland MC; Prins GS; Swanson SM
    Endocrinology; 2008 Mar; 149(3):1366-76. PubMed ID: 18079205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.
    Wang Z; Prins GS; Coschigano KT; Kopchick JJ; Green JE; Ray VH; Hedayat S; Christov KT; Unterman TG; Swanson SM
    Endocrinology; 2005 Dec; 146(12):5188-96. PubMed ID: 16141391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y; Yokohira M; Saoo K; Takeuchi H; Chen Y; Yamakawa K; Matsuda Y; Kakehi Y; Imaida K
    Carcinogenesis; 2005 Jun; 26(6):1109-16. PubMed ID: 15731164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.
    Cho YM; Takahashi S; Asamoto M; Suzuki S; Inaguma S; Hokaiwado N; Shirai T
    Cancer Sci; 2003 Feb; 94(2):153-7. PubMed ID: 12708490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Jun; 78(6):i-xv. PubMed ID: 9645768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical exercise on the rat ventral prostate: steroid hormone receptors, apoptosis and cell proliferation.
    Teixeira GR; Fávaro WJ; Pinheiro PF; Chuffa LG; Amorim JP; Mendes LO; Fioruci BA; Oba E; Martins OA; Martinez M; Martinez FE
    Scand J Med Sci Sports; 2012 Oct; 22(5):e86-92. PubMed ID: 22830442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer.
    Wang Y; Kasper S; Yuan J; Jin RJ; Zhang J; Ishii K; Wills ML; Hayward SW; Matusik RJ
    Lab Invest; 2006 Oct; 86(10):1074-88. PubMed ID: 16894353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
    Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
    Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.
    Huss WJ; Gray DR; Tavakoli K; Marmillion ME; Durham LE; Johnson MA; Greenberg NM; Smith GJ
    Neoplasia; 2007 Nov; 9(11):938-50. PubMed ID: 18030362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
    Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
    Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.
    Xie W; Wong YC; Tsao SW
    Prostate; 2000 Jun; 44(1):31-9. PubMed ID: 10861755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.